首页> 外文期刊>International Journal of Nephrology and Renovascular Disease >Clinical, patient-related, and economic outcomes of home-based high-dose hemodialysis versus conventional in-center hemodialysis
【24h】

Clinical, patient-related, and economic outcomes of home-based high-dose hemodialysis versus conventional in-center hemodialysis

机译:家用大剂量血液透析与常规中心血液透析的临床,患者相关和经济结果

获取原文
获取外文期刊封面目录资料

摘要

Despite technological advances in renal replacement therapy, the preservation of health and quality of life for individuals on dialysis still remains a challenge. The high morbidity and mortality in dialysis warrant further research and insight into the clinical domains of the technique and practice of this therapy. In the last 20 years, the focus of development in the field of hemodialysis (HD) has centered around adequate removal of urea and other associated toxins. High-dose HD offers an opportunity to improve mortality, morbidity, and quality of life of patients with end-stage kidney disease. However, the uptake of this modality is low, and the risk associated with the therapy is not fully understood. Recent studies have highlighted the evidence base and improved our understanding of this technique of dialysis. This article provides a review of high-dose and home HD, its clinical impact on patient outcome, and the controversies that exist.
机译:尽管肾脏替代疗法在技术上取得了进步,但透析患者个人的健康和生活质量仍然是一个挑战。透析的高发病率和高死亡率值得进一步研究和深入了解该疗法的技术和实践的临床领域。在过去的20年中,血液透析(HD)领域的发展重点集中在充分去除尿素和其他相关毒素上。高剂量HD提供了改善终末期肾脏疾病患者的死亡率,发病率和生活质量的机会。但是,这种方式的吸收率很低,并且与治疗相关的风险尚未得到充分了解。最近的研究突出了证据基础并增进了我们对这种透析技术的理解。本文对高剂量和家庭高清,其对患者预后的临床影响以及存在的争议进行了综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号